COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling

Area of Science:

• Immunology
• Virology
• Genomics

Background:

• COVID-19, caused by SARS-CoV-2, involves complex inflammation and immune alterations.
• While immune responses in respiratory tracts and blood are known, their impact on cell heterogeneity and disease progression remains unclear.

Purpose of the Study:

• To investigate immune cell heterogeneity and its correlation with disease progression in COVID-19 patients.
• To identify novel immune cell surface markers and receptors affected by SARS-CoV-2 infection.

Main Methods:

• Single-cell RNA sequencing was performed on peripheral blood mononuclear cells (PBMCs) from 50 COVID-19 patients and 27 healthy controls.
• Analysis focused on approximately 400 transcripts related to immune cell function, including surface markers.

Main Results:

• COVID-19 patients showed increased expression of COVID-specific surface markers across various immune cell subsets.
• Reduced expression of IFNGR1 and CXCR4 receptors was observed, correlating with inhibited signaling pathways and immune functions.
• These changes were associated with COVID-19 clinical outcomes.

Conclusions:

• Novel immunoreceptors are selectively expressed in COVID-19 patients, impacting immune functionality.
• Understanding these immune alterations is crucial for correlating them with clinical outcomes and disease progression.